Accordingly, a Kaplan–Meier analysis suggested that leptin overexpression is a positive prognosticator of disease-free survival (DFS) along with disease-specific survival (DSS) in ovarian cancer patients [196]. The gene discussed is LEP; the disease is ovarian carcinoma.